Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Botulinum toxin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Depression=== {{See also|List of investigational antidepressants}} A few small trials have found benefits in people with [[depression (mood)|depression]].<ref>{{cite journal |vauthors = Magid M, Keeling BH, Reichenberg JS |title = Neurotoxins: Expanding Uses of Neuromodulators in Medicine--Major Depressive Disorder |journal = Plastic and Reconstructive Surgery |volume = 136 |issue = 5 Suppl |pages = 111S–119S |date = November 2015 |pmid = 26441090 |doi = 10.1097/PRS.0000000000001733 |s2cid = 24196194 }}</ref><ref name="AdisInsight" /><ref name="Ceolato-Martin_2024">{{Cite journal |vauthors = Ceolato-Martin C, Chevallier-Collins C, Clément JP, Charles E, Lacroix A, Ranoux D |date=January 2024 |veditors = Ai S |title=OnabotulinumtoxinA in Resistant Depression: A Randomized Trial Comparing Two Facial Injection Sites (OnaDEP Study) |journal=Depression and Anxiety |language=en |volume=2024 |issue=1 |doi=10.1155/2024/1177925 |doi-access=free |pmid=40226647 |issn=1091-4269|pmc=11918888 }}</ref> A 2021 meta-analysis supports the usefulness of botox in unipolar depression, but finds significant heterogenity among the findings.<ref>{{cite journal |vauthors = Arnone D, Galadari H, Rodgers CJ, Östlundh L, Aziz KA, Stip E, Young AH |title = Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials |journal = Journal of Psychopharmacology |volume = 35 |issue = 8 |pages = 910–918 |date = August 2021 |pmid = 33719696 |pmc = 8366169 |doi = 10.1177/0269881121991827 }}</ref> The main hypothesis for its action is based on the [[facial feedback hypothesis]].<ref>{{cite journal |vauthors = Finzi E, Rosenthal NE |title = Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial |journal = Journal of Psychiatric Research |volume = 52 |pages = 1–6 |date = May 2014 |pmid = 24345483 |doi = 10.1016/j.jpsychires.2013.11.006 }}</ref> Another hypothesis involves a connection between the facial muscle and specific brain regions in animals, but additional evidence is required to support or disprove this theory.<ref name="Ceolato-Martin_2024" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)